ALTIMMUNE, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ALTIMMUNE, INC. (ALT) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$45.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-12
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$22.82M.
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$22.56M.
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$27.36M.
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$19.01M.
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$88.09M.
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$95.06M.
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$88.45M.
- ALTIMMUNE, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$84.71M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$22.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$45.39M 10-Q · filed 2026-08-12 | -$72.75M derived: sum of 3 quarters · filed 2026-08-12 | -$91.76M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$22.56M 10-Q · filed 2026-05-13 | -$49.92M derived: sum of 2 quarters · filed 2026-05-13 | -$68.94M derived: sum of 3 quarters · filed 2026-05-13 | -$91.08M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$27.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$46.37M derived: sum of 2 quarters · filed 2026-03-06 | -$68.52M derived: sum of 3 quarters · filed 2026-08-12 | -$88.09M 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | -$19.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$41.16M derived: sum of 2 quarters · filed 2026-08-12 | -$60.73M 10-Q · filed 2025-11-06 | -$83.92M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$22.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$41.72M 10-Q · filed 2026-08-12 | -$64.90M derived: sum of 3 quarters · filed 2026-08-12 | -$87.75M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$19.57M 10-Q · filed 2026-05-13 | -$42.76M derived: sum of 2 quarters · filed 2026-05-13 | -$65.60M derived: sum of 3 quarters · filed 2026-05-13 | -$90.24M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$23.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$46.02M derived: sum of 2 quarters · filed 2026-03-06 | -$70.67M derived: sum of 3 quarters · filed 2026-03-06 | -$95.06M 10-K · filed 2026-03-06 | ||||
| 2024-09-30 | -$22.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$47.48M derived: sum of 2 quarters · filed 2025-11-06 | -$71.88M 10-Q · filed 2025-11-06 | -$103.52M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$24.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$49.03M 10-Q · filed 2025-08-12 | -$80.67M derived: sum of 3 quarters · filed 2025-08-12 | -$101.35M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$24.39M 10-Q · filed 2025-05-13 | -$56.03M derived: sum of 2 quarters · filed 2025-05-13 | -$76.71M derived: sum of 3 quarters · filed 2025-05-13 | -$92.77M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$31.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$52.31M derived: sum of 2 quarters · filed 2025-02-27 | -$68.37M derived: sum of 3 quarters · filed 2025-02-27 | -$88.45M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | -$20.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$36.73M derived: sum of 2 quarters · filed 2024-11-12 | -$56.81M 10-Q · filed 2024-11-12 | -$78.47M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$16.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$36.13M 10-Q · filed 2024-08-08 | -$57.80M derived: sum of 3 quarters · filed 2024-08-08 | -$81.31M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$20.07M 10-Q · filed 2024-05-09 | -$41.73M derived: sum of 2 quarters · filed 2024-05-09 | -$65.25M derived: sum of 3 quarters · filed 2024-05-09 | -$85.36M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$21.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$45.18M derived: sum of 2 quarters · filed 2024-03-27 | -$65.28M derived: sum of 3 quarters · filed 2024-03-27 | -$84.71M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$23.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$43.62M derived: sum of 2 quarters · filed 2023-11-07 | -$63.05M 10-Q · filed 2023-11-07 | -$86.94M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$20.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$39.54M 10-Q · filed 2023-08-10 | -$63.43M derived: sum of 3 quarters · filed 2023-08-10 | -$96.94M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$19.43M 10-Q · filed 2023-05-11 | -$43.32M derived: sum of 2 quarters · filed 2023-05-11 | -$76.83M derived: sum of 3 quarters · filed 2023-05-11 | -$101.66M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$23.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$57.40M derived: sum of 2 quarters · filed 2023-02-28 | -$82.23M derived: sum of 3 quarters · filed 2023-02-28 | -$97.09M 10-K · filed 2023-02-28 | -$97.09M 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$33.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$58.34M derived: sum of 2 quarters · filed 2022-11-10 | -$73.20M 10-Q · filed 2022-11-10 | -$73.20M 10-Q · filed 2021-11-09 | -$83.82M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$24.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$39.69M 10-Q · filed 2022-08-11 | -$39.69M 10-Q · filed 2021-08-10 | -$50.31M derived: sum of 3 quarters · filed 2022-08-11 | -$68.08M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$14.86M 10-Q · filed 2022-05-12 | -$14.86M 10-Q · filed 2021-05-17 | -$25.49M derived: sum of 2 quarters · filed 2022-05-12 | -$43.26M derived: sum of 3 quarters · filed 2022-05-12 | -$60.02M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$28.39M derived: sum of 2 quarters · filed 2022-03-15 | -$45.16M derived: sum of 3 quarters · filed 2022-03-15 | -$49.04M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | -$17.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$34.54M derived: sum of 2 quarters · filed 2021-11-09 | -$38.42M 10-Q · filed 2021-11-09 | -$42.52M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | -$16.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$20.65M 10-Q · filed 2021-08-10 | -$24.75M derived: sum of 3 quarters · filed 2021-08-10 | -$35.69M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$3.89M 10-Q · filed 2021-05-17 | -$7.98M derived: sum of 2 quarters · filed 2021-05-17 | -$18.92M derived: sum of 3 quarters · filed 2021-05-17 | -$22.31M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$15.04M derived: sum of 2 quarters · filed 2021-02-25 | -$18.42M derived: sum of 3 quarters · filed 2021-02-25 | -$20.52M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | -$10.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$14.33M derived: sum of 2 quarters · filed 2020-11-09 | -$16.42M 10-Q · filed 2020-11-09 | -$40.93M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$5.48M 10-Q · filed 2020-08-11 | -$29.99M derived: sum of 3 quarters · filed 2020-08-11 | -$32.34M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | -$2.10M 10-Q · filed 2020-05-13 | -$26.60M derived: sum of 2 quarters · filed 2020-05-13 | -$28.96M derived: sum of 3 quarters · filed 2020-05-13 | -$38.09M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | -$24.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$26.86M derived: sum of 2 quarters · filed 2020-03-27 | -$36.00M derived: sum of 3 quarters · filed 2020-03-27 | -$39.17M 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$11.49M derived: sum of 2 quarters · filed 2019-11-13 | -$14.66M 10-Q · filed 2019-11-13 | -$23.49M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$9.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$12.31M 10-Q · filed 2019-08-13 | -$21.14M derived: sum of 3 quarters · filed 2019-08-13 | -$51.05M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$3.17M 10-Q · filed 2019-05-14 | -$12.00M derived: sum of 2 quarters · filed 2019-05-14 | -$41.91M derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | -$8.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$38.74M derived: sum of 2 quarters · filed 2019-04-01 | -$46.43M 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | -$29.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$37.59M 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | -$7.69M 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |